Demand for live streaming of online seminars and other events in the pharmaceutical sector

「The Group sought to maintain business by combining proposals for video initiatives such as subtitle generation using generative AI, highly specialized content production by Group companies, the data analytics tool WebinarAnalytics and advertising initiatives. However, among the company's major customers, the year-on-year decline in the company's sales was greater among Japanese companies than among foreign-affiliated companies, partly because of trends in customers' business performance. As multi-vendor adoption advanced, new customer acquisition and growth in transaction size with mid-sized customers remained solid, but lower unit prices for live-streaming projects and the scale of transactions were insufficient to offset the decline in major customers. The company's standalone cumulative full-year revenue in this area fell below the previous year.」

「In the EVC segment (pharmaceuticals), orders for related services such as live streaming for web seminars and audience-acquisition advertising continued, but pharmaceutical companies' DX investment varied because of the effects of drug price revisions and the launch status of products. Demand from major customers in foreign-affiliated companies remained relatively stable, while many Japanese companies recorded lower demand than in the previous year. The Group sought to win projects through proprietary channels by combining proposals for video initiatives, including subtitle generation using generative AI and the data analytics tool WebinarAnalytics, with highly specialized content production by Group companies. Web and other production performed relatively well, but the average unit price of live-streaming projects declined because of a decrease in high-value projects obtained through agencies, while the decline in video production projects also contributed to overall performance falling below the year-earlier period.」

「In the EVC segment (pharmaceuticals), orders continued in areas including the core live streaming for web seminars, audience acquisition and other arrangements associated with events, reflecting pharmaceutical companies' promotion of DX initiatives, although the degree of focus on these initiatives varied among pharmaceutical customers. During the interim consolidated accounting period, performance remained weak because major web seminar promotions by large customers were less substantial than in the previous fiscal year and some companies reduced their sales promotion budgets. Demand remained high for the data analytics tools effective in pharmaceutical marketing provided by the company and for content production used in pharmaceutical marketing. Revenue from existing customers was solid, and these offerings also contributed to new customer development as the Group expanded them. However, revenue across the area fell short of the previous year.」

「In the EVC segment (pharmaceuticals), the degree of focus on core areas such as live streaming for web seminars, audience acquisition and other arrangements associated with events continued to decline from the COVID-19 period because of factors including responses to drug price revisions and the declining relative position of the Japanese market due to the weaker yen. Even in the third quarter, which had been a busy period in previous fiscal years, the increase in demand was relatively modest.」

「In the EVC segment (pharmaceuticals), orders continued in areas including the core live streaming for web seminars, audience acquisition and other arrangements associated with events, reflecting pharmaceutical companies' promotion of DX initiatives. However, except for some companies, the degree of focus continued to decline from the COVID-19 period because of factors including responses to drug price revisions and the declining relative position of the Japanese market due to the weaker yen. The general trend toward placing greater emphasis on measuring effectiveness also strengthened. Some of the company's major customers moved to narrow the scope of live events because of budget constraints, while advertising and audience-acquisition demand focused more strongly on marketing effectiveness increased as a proportion of demand. Revenue across the area, including live streaming and related web and video production services, fell short of the previous year, including at consolidated subsidiaries whose primary customers are pharmaceutical companies.」

「In the EVC segment (pharmaceuticals), orders continued in areas including the core live streaming for web seminars, audience acquisition and other arrangements associated with events, reflecting pharmaceutical companies' promotion of DX initiatives. However, the degree of focus on these initiatives varied among pharmaceutical customers, while demands for cost-effectiveness generally strengthened. Some of the company's major customers also moved to narrow the scope of their events, while demand related to event audience acquisition increased, reflecting a stronger emphasis on marketing effectiveness. Revenue across the area, including live streaming and related web, video and other services, fell short of the previous year.」

「Revenue across this area, including live streaming and related web, video and other services, fell short of the previous year.」

「In the EVC segment (pharmaceuticals), orders continued in areas including the core live streaming for web seminars, audience acquisition and other arrangements associated with events, reflecting pharmaceutical companies' promotion of DX initiatives. With growth in Japan's pharmaceutical market continuing to lag that of other countries, the slowdown in sales promotion activities by major customers resulted in cumulative performance falling short of the year-earlier period. However, during the busy third quarter, a period with many events, orders including those from newly developed customers substantially exceeded the year-earlier period.」

「In the EVC segment (pharmaceuticals), orders continued in areas including the core live streaming for web seminars, audience acquisition and other arrangements associated with events, reflecting pharmaceutical companies' promotion of DX initiatives. However, with growth in Japan's pharmaceutical market continuing to lag that of other countries, the slowdown in sales promotion activities by major customers had a significant impact, and results fell short of the year-earlier period.」

「In the EVC segment (pharmaceuticals), orders continued in areas including the core live streaming for web seminars, audience acquisition and other arrangements associated with events, reflecting pharmaceutical companies' promotion of DX initiatives. However, results fell short of the year-earlier period, when orders had been brought forward to avoid the Olympic period.」

「Partly because a major customer temporarily scaled back its events, revenue in this area, centered on live-streaming revenue, fell short of the initial forecast. Video production also remained weak and below expectations as the decline following the previous fiscal year's production demand generated by the sudden response to the COVID-19 pandemic became apparent.」

「Although companies pursuing proactive initiatives were prominent in the first quarter, thereafter some companies continued to expand proactively while others reduced the number of events from the previous year. Event-related revenue exceeded the previous year on a cumulative basis, but in the third quarter fell short of the initial forecast. Video production also remained weak, particularly because there was less production demand arising from unexpected surplus budgets than in the previous year.」

「In the EVC segment (pharmaceuticals), the drive to promote digital transformation (DX), which had become evident in the previous fiscal year, continued. Revenue from live streaming for web seminars and from arrangements related to live events performed well. Although some events were rescheduled to before or after the summer because of the Olympics, overall revenue exceeded the previous year and continued to grow.」

「In the EVC segment (pharmaceuticals), the drive to promote digital transformation (DX), which had become evident in the previous fiscal year, continued. Revenue from live streaming for web seminars and from arrangements related to live events performed well. Related web production also performed well, resulting in revenue more than double that of the year-earlier period and substantial growth.」

「Revenue from live streaming for web seminars increased substantially for many customers. Related web and video production also remained solid, resulting in revenue more than double that of the year-earlier period and substantial growth.」

「In the EVC segment (pharmaceuticals), visits by medical representatives and sales promotion activities were restricted in some cases as part of infection-control measures. As a result, revenue from live streaming for web seminars increased substantially for multiple customers, while related web and video production also remained solid, resulting in revenue more than double that of the year-earlier period and substantial growth.」

「In the EVC segment (pharmaceuticals), visits by medical representatives and sales promotion activities were restricted in some cases as part of infection-control measures. As a result, revenue from live streaming for web seminars increased substantially for multiple customers, while related web and video production also remained solid, resulting in revenue more than double that of the year-earlier period and substantial growth.」

「In the EVC segment (pharmaceuticals), visits by medical representatives and sales promotion activities were restricted in some cases as part of infection-control measures. As a result, revenue from live streaming for web seminars increased substantially for multiple customers, while related web production also remained solid. Revenue from video and other content production for e-detailing by Big M's Wye Co., Ltd., which became a wholly owned subsidiary in August 2019, and from live streaming also performed well.」

「Orders for web seminars increased because they reduce opportunities for in-person contact」

「Orders for live-streaming services, mainly for the pharmaceutical industry, also exceeded the year-earlier period.」

「Orders for live-streaming services, mainly for the pharmaceutical industry, also exceeded the year-earlier period.」

「Although orders for live-streaming projects for the provision of information through online seminars and other events by pharmaceutical companies fluctuated substantially in value depending on the customer, overall orders exceeded those in the same period of the previous year.」

「During the consolidated fiscal year, orders for internet live-streaming projects, used mainly by pharmaceutical companies to provide product information, fell short of expectations.」

「Orders for internet live-streaming projects, used mainly by pharmaceutical companies to provide product information, fell short of expectations.」

「Orders for live-streaming projects, mainly in the pharmaceutical sector, fell short of expectations.」

「Orders for live-streaming projects, mainly in the pharmaceutical sector, fell short of expectations.」

「During the cumulative third quarter, orders for live-streaming projects related to the provision of information through online seminars and other events by pharmaceutical companies increased substantially year on year.」

「During the cumulative second quarter, orders for live-streaming projects related to the provision of information through online seminars and other events by pharmaceutical companies increased substantially year on year.」

「During the cumulative first quarter, orders for live-streaming projects related to the provision of information through online seminars and other events by companies in the pharmaceutical sector increased substantially year on year.」

「During the cumulative third quarter, orders for live-streaming projects related to the provision of information through online seminars and other events by companies in the pharmaceutical sector increased.」

「During the cumulative second quarter, orders for live-streaming projects related to the provision of information through online seminars and other events by companies in the pharmaceutical sector increased.」

「Demand remained solid for projects involving live streaming and related content production, mainly in the pharmaceutical sector, while orders from other industries also generally remained stable and followed an upward revenue trend.」